Support

Support Options

Report a problem

About you
This is a randomly generated image of letters and numbers. Letters not clear? Click to renew CAPTCHA.
About the problem

Sudha Sudesh Sundar

Profile

  • What would you like us to know about you?
    Sudha Sundar is a gynaecological cancer surgeon and Professor of Gynaecological Cancer at the University of Birmingham. She trained in Obstetrics and Gynaecology at Oxford and in Gynaecological Oncology at the Three Counties cancer centre, Gloucestershire. Sudha trained in Molecular Oncology as a Cancer Research UK Clinical Fellow at the Weatherall Institute of Molecular Medicine, Oxford. She is the current President-Elect of the British Gynaecological Cancer Society, the first women gynaecological oncologist to be elected to this post. Sudha's research interests are in early cancer diagnosis, surgical outcomes after cancer surgery and cancer genomics. In the UK, she runs a research programme on early cancer diagnosis in the UK ( www.birmingham.ac.uk/ROCkeTS); this combines clinical trials with parallel projects in metabolomics, steroidomics and genomics and dataset mining Surgical Outcomes in cancer surgery - Sudha is cancer surgery work package lead for the NIHR global health research unit on Global Surgery; this capacity builds for surgical research across sub-Saharan Africa, India and other countries. The unit is currently undertaking a Global Cancer Surgery cohort study across 25 countries, including India and has recruited 10,000 patients already. A feasibility trial funded by the MRC to identify and evaluate low cost sustainable nutrition interventions for patients undergoing cancer surgery has also just commenced. Ethnic Diversity in Cancer genomics – Working with Profs Ian Tomlinson, Jean-Baptiste Cazier, and partners across India ( PGIMER, PHFI) and Africa we are establishing matched cohort studies UK-India to investigate ethnic diversity in women’s cancer genomics. https://www.birmingham.ac.uk/news/latest/2018/02/ethnic-diversity-in-cancer-genomics-workshop.aspx. A matched cohort study in PGIMER. Chandigarh and Birmingham, UK for next generation sequencing using panel testing in women with Breast and Ovarian cancer is underway.

  • ORCiD
    (not set)

The opinions, findings, and conclusions or recommendations expressed on this site are those of the author(s) and do not necessarily reflect the views of Knowinnovation Inc.